Celyad Oncology - ADR
CYAD
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.24M
Close$
Share Statistics
| Market cap | $14.24 Million |
|---|---|
| Enterprise Value | $9.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.14 |
| Beta | 1.69 |
| Outstanding Shares | 41,429,000 |
Return
| Return on Equity | -437.12% |
|---|---|
| Return on Assets | -111.10% |
| Return on Invested Capital | -146.91% |
Valuation & Multiples
| P/E Ratio | 13.48 |
|---|---|
| PEG | -32.93 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 32.29 |
| Enterprise Value to EBIT | -0.61 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Celyad Oncology
CEO: Filippo Petti